Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

— Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the U.S. Food & Drug Administration (“U.S. FDA”) has approved the Company to proceed with a randomized, double-blind, placebo-controlled confirmatory PhaseContinue reading “Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19”

Relevium Technologies and H-Source Holdings Partner for the Strategic Development and Global Supply of Personal Protective Equipment

— Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce it has entered into a Letter of Intent (“LOI”) with H-Source Holdings, a leading secure and trusted Personal Protective Equipment (“PPE”) platform, to partner in the development, strategic sourcing and supply of global PPE requirements dueContinue reading “Relevium Technologies and H-Source Holdings Partner for the Strategic Development and Global Supply of Personal Protective Equipment”

Future Farm and High Purity Natural Products Complete Merger

Future Farm Continues Financial, Strategic and Administrative Support for High Purity’s Cutting-Edge Sales and Advanced Manufacturing Operation High Purity’s Team, Built by Industry Leader Mike Matton, Brings Outstanding Expertise Core Strategy of the Combined Company is Increasing Market Share in the Health and Wellness Market, Targeting Hemp-Derived CBD products and Hand Sanitizer – Future FarmContinue reading “Future Farm and High Purity Natural Products Complete Merger”

Naturally Splendid Provides 2019 in Review and 2020 Outlook

— Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) announces its audited financial results for the year ended December 31, 2019. All amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards. Naturally Splendid recorded a net loss and comprehensive loss for the year of $7,030,070 during the year ended December 31,Continue reading “Naturally Splendid Provides 2019 in Review and 2020 Outlook”